Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin plus intensive insulin therapy in newly diagnosed type 2 diabetes
ChiCTR1800015822Phase 4Recruiting
- Sponsor
- Tung Wah Hospital
- Start
- May 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin and human insulin in type 2 diabetes mellitus (T2DM), sponsored by Tung Wah Hospital. Primary endpoints: HOMA-IR and HOMA-beta. Started May 2018; status: recruiting.
02
Drugs
dapagliflozinhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800015822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015822.